Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
ACE Report #8662
Ace Report Cover Shoulder & Elbow

AAOS 2016: Liposomal bupivacaine versus interscalene nerve block in shoulder arthroplasty

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Liposomal Bupivacaine Versus Interscalene Nerve Block in Managing Pain After Shoulder Arthroplasty

Contributing Authors: K Okoroha RA Keller J Lynch J Korona BK Rill PA Kolowich SJ Muh

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.


80 patients undergoing either total shoulder arthroplasty (TSA) or reverse TSA were included in the study. The study was conducted in order to identify the optimal postoperative pain management regimen between locally infiltrated liposomal bupivacaine and an interscalene nerve block, thus patients were randomized to receive one of the above interventions. Findings showed no significant differences...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.